These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis. Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174 [TBL] [Abstract][Full Text] [Related]
3. Recurrent laryngeal papillomatosis with oesophageal involvement in a 2 year old boy: successful treatment with the quadrivalent human papillomatosis vaccine. Mészner Z; Jankovics I; Nagy A; Gerlinger I; Katona G Int J Pediatr Otorhinolaryngol; 2015 Feb; 79(2):262-6. PubMed ID: 25496821 [TBL] [Abstract][Full Text] [Related]
4. Lower airway papillomatosis in children. Zawadzka-Głos L; Jakubowska A; Chmielik M; Bielicka A; Brzewski M Int J Pediatr Otorhinolaryngol; 2003 Oct; 67(10):1117-21. PubMed ID: 14550967 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of pediatric laryngopharyngeal reflux. Karkos PD; Apostolidou MT; Apostolidis T Int J Pediatr Otorhinolaryngol; 2006 Apr; 70(4):757-8; author reply 759. PubMed ID: 16242786 [No Abstract] [Full Text] [Related]
8. [Human papillomavirus-DNA in laryngeal papilloma detected by nucleic acid hybridization and the clinical treatment]. Liu DJ Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(6):358-9, 382. PubMed ID: 8031590 [TBL] [Abstract][Full Text] [Related]
9. [Molecular-biological aspects of juvenile respiratory papillomatosis and its combined treatment]. Geraĭn V; Chireshkin DG Vestn Otorinolaringol; 1996; (4):3-8. PubMed ID: 8966875 [TBL] [Abstract][Full Text] [Related]
10. [Virologic aspects of juvenile laryngeal papillomatosis]. Major T; Jókay I; Soós G; Gergely L; Czeglédy J Orv Hetil; 1999 Feb; 140(8):405-9. PubMed ID: 10083813 [TBL] [Abstract][Full Text] [Related]
11. [Laryngeal papillomatosis. Role of human papilloma virus, perspectives of the diagnosis and treatment]. Antoniv VF; Mitskonas A; Antoniv TV; Matela II Vestn Otorinolaringol; 2004; (3):54-7. PubMed ID: 15341014 [No Abstract] [Full Text] [Related]
14. Virological and immunological aspects in the juvenile laryngeal papillomatosis. Gheorghe DC; Ardelean C; Anton G Rom J Virol; 1999; 50(1-4):85-9. PubMed ID: 11601383 [TBL] [Abstract][Full Text] [Related]
16. Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years. Kocjan BJ; Gale N; Hočevar Boltežar I; Seme K; Fujs Komloš K; Hošnjak L; Maver PJ; Jelen MM; Zupanič Pajnič I; Balažic J; Poljak M J Infect Dis; 2013 Feb; 207(4):583-7. PubMed ID: 23204170 [TBL] [Abstract][Full Text] [Related]
17. Contemporary management of laryngeal papilloma in adults and children. Andrus JG; Shapshay SM Otolaryngol Clin North Am; 2006 Feb; 39(1):135-58. PubMed ID: 16469660 [No Abstract] [Full Text] [Related]
18. Extraesophageal acid reflux and recurrent respiratory papilloma in children. McKenna M; Brodsky L Int J Pediatr Otorhinolaryngol; 2005 May; 69(5):597-605. PubMed ID: 15850681 [TBL] [Abstract][Full Text] [Related]
19. Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis. Creelan BC; Ahmad MU; Kaszuba FJ; Khalil FK; Welsh AW; Ozdemirli M; Grant NN; Subramaniam DS Oncologist; 2019 Jun; 24(6):829-835. PubMed ID: 30842242 [TBL] [Abstract][Full Text] [Related]
20. Treatment of paediatric laryngeal papillomas: web survey of British Association of Paediatric Otolaryngologists. Manickavasagam J; Wu K; Bateman ND J Laryngol Otol; 2013 Sep; 127(9):917-21. PubMed ID: 23927772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]